MetLife, Inc. (NYSE:MET) – Analysts at Langen Mcalenn decreased their Q2 2018 earnings estimates for shares of MetLife in a research note issued to investors on Monday. Langen Mcalenn analyst L. Greenberg now forecasts that the financial services provider will post earnings of $1.43 per share for the quarter, down from their prior estimate of $1.44. Langen Mcalenn also issued estimates for MetLife’s Q3 2018 earnings at $1.52 EPS, Q4 2018 earnings at $1.53 EPS and FY2018 earnings at $5.90 EPS.

MetLife (NYSE:MET) last posted its quarterly earnings data on Wednesday, August 2nd. The financial services provider reported $1.30 EPS for the quarter, beating the Thomson Reuters’ consensus estimate of $1.28 by $0.02. MetLife had a net margin of 0.30% and a return on equity of 8.51%. The business had revenue of $17.39 billion during the quarter, compared to analyst estimates of $17.11 billion. During the same quarter last year, the firm posted $0.83 earnings per share. The business’s revenue for the quarter was up 2.5% compared to the same quarter last year.

TRADEMARK VIOLATION NOTICE: This news story was reported by American Banking News and is the property of of American Banking News. If you are accessing this news story on another domain, it was stolen and republished in violation of international copyright and trademark laws. The original version of this news story can be read at https://www.americanbankingnews.com/2017/08/08/q2-2018-eps-estimates-for-metlife-inc-met-reduced-by-langen-mcalenn.html.

MET has been the subject of several other reports. Citigroup Inc. set a $51.00 target price on MetLife and gave the company a “sell” rating in a research note on Friday, July 7th. Royal Bank Of Canada reiterated a “buy” rating and set a $62.00 target price on shares of MetLife in a research note on Wednesday, July 12th. Wells Fargo & Company reiterated an “outperform” rating and set a $63.00 target price (up from $61.00) on shares of MetLife in a research note on Wednesday, July 12th. Keefe, Bruyette & Woods reiterated a “buy” rating and set a $59.00 target price on shares of MetLife in a research note on Thursday, August 3rd. Finally, TheStreet upgraded MetLife from a “c” rating to a “b-” rating in a research note on Monday, July 24th. Two research analysts have rated the stock with a sell rating, six have assigned a hold rating, seven have assigned a buy rating and one has assigned a strong buy rating to the stock. The stock currently has an average rating of “Hold” and an average price target of $59.02.

MetLife (MET) traded up 0.31% on Tuesday, hitting $48.68. 1,631,916 shares of the stock traded hands. The firm’s 50-day moving average price is $54.59 and its 200-day moving average price is $53.07. The stock has a market cap of $52.93 billion, a price-to-earnings ratio of 546.97 and a beta of 1.46. MetLife has a 12-month low of $38.87 and a 12-month high of $58.09.

Institutional investors have recently added to or reduced their stakes in the stock. Atria Investments LLC raised its position in MetLife by 2.6% in the first quarter. Atria Investments LLC now owns 18,914 shares of the financial services provider’s stock worth $999,000 after buying an additional 488 shares during the period. Prospera Financial Services Inc bought a new position in MetLife during the first quarter worth $1,525,000. Tompkins Financial Corp raised its position in MetLife by 40.8% in the first quarter. Tompkins Financial Corp now owns 7,789 shares of the financial services provider’s stock worth $342,000 after buying an additional 2,258 shares during the period. Aberdeen Asset Management PLC UK raised its position in MetLife by 1.3% in the first quarter. Aberdeen Asset Management PLC UK now owns 469,645 shares of the financial services provider’s stock worth $24,807,000 after buying an additional 6,188 shares during the period. Finally, Zurcher Kantonalbank Zurich Cantonalbank raised its position in MetLife by 4.2% in the first quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 393,208 shares of the financial services provider’s stock worth $20,769,000 after buying an additional 15,716 shares during the period. Institutional investors and hedge funds own 74.83% of the company’s stock.

The company also recently announced a quarterly dividend, which will be paid on Wednesday, September 13th. Investors of record on Monday, August 7th will be issued a dividend of $0.40 per share. This represents a $1.60 dividend on an annualized basis and a yield of 3.30%. The ex-dividend date of this dividend is Thursday, August 3rd. MetLife’s payout ratio is currently 1,777.98%.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Earnings History and Estimates for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.